Drug Shortage Report for MINT-OLANZAPINE ODT
Report ID | 35470 |
Drug Identification Number | 02436973 |
Brand name | MINT-OLANZAPINE ODT |
Common or Proper name | Olanzapine ODT |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 30 Count Blisters |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-01-09 |
Actual start date | 2018-01-09 |
Estimated end date | 2018-06-29 |
Actual end date | 2018-07-24 |
Shortage status | Resolved |
Updated date | 2018-07-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2018-07-25 | English | Compare |
v11 | 2018-07-24 | French | Compare |
v10 | 2018-07-24 | English | Compare |
v9 | 2018-06-01 | French | Compare |
v8 | 2018-06-01 | English | Compare |
v7 | 2018-05-15 | French | Compare |
v6 | 2018-05-15 | English | Compare |
v5 | 2018-04-12 | French | Compare |
v4 | 2018-04-12 | English | Compare |
v3 | 2018-01-10 | English | Compare |
v2 | 2018-01-09 | French | Compare |
v1 | 2018-01-09 | English | Compare |
Showing 1 to 12 of 12